Published in Cell on March 24, 1995
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles (2013) 4.05
Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci U S A (2002) 3.01
Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol (1996) 2.96
Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A (1999) 2.33
Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood (2014) 2.01
Lysophosphatidic acid and microtubule-destabilizing agents stimulate fibronectin matrix assembly through Rho-dependent actin stress fiber formation and cell contraction. Mol Biol Cell (1997) 1.96
The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol (2009) 1.78
Lipid phosphate phosphatases and signaling. J Lipid Res (2008) 1.70
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther (2009) 1.61
Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood (2011) 1.48
The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest (1997) 1.43
A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J Lipid Res (2000) 1.42
Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochim Biophys Acta (2008) 1.34
Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther (2005) 1.28
Therapeutic potential of autotaxin/lysophospholipase d inhibitors. Curr Drug Targets (2008) 1.27
Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol (2015) 1.23
Circulating microparticles: square the circle. BMC Cell Biol (2013) 1.14
Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid. EMBO J (1998) 1.09
Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J Exp Med (2013) 1.08
Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin Invest (1998) 1.07
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Biochim Biophys Acta (2012) 1.04
The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation. J Immunol (2014) 1.04
Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2. Proc Natl Acad Sci U S A (1998) 1.03
The immune functions of phosphatidylserine in membranes of dying cells and microvesicles. Semin Immunopathol (2010) 1.03
Bench-to-bedside review: circulating microparticles--a new player in sepsis? Crit Care (2010) 1.02
Lysophosphatidic acid in atherosclerotic diseases. Br J Pharmacol (2012) 1.01
Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis (2007) 1.01
Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. Mol Carcinog (2009) 1.00
Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis. J Lipid Res (2002) 0.97
Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators. Mol Pharmacol (2009) 0.96
Red blood cell vesiculation in hereditary hemolytic anemia. Front Physiol (2013) 0.95
Kinetic evaluation of cell membrane hydrolysis during apoptosis by human isoforms of secretory phospholipase A2. J Biol Chem (2010) 0.94
The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation. J Lipid Res (2011) 0.93
Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production. J Biol Chem (2002) 0.92
Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci (2005) 0.92
Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597). PLoS One (2014) 0.92
Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci U S A (2015) 0.92
Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI. Biochem J (1997) 0.92
Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models. Oncogene (2011) 0.92
T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomes. J Cell Mol Med (2013) 0.91
Relationship between membrane physical properties and secretory phospholipase A2 hydrolysis kinetics in S49 cells during ionophore-induced apoptosis. Biophys J (2007) 0.91
Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium. Ann Rheum Dis (1998) 0.91
High specificity of human secretory class II phospholipase A2 for phosphatidic acid. Biochem J (1997) 0.90
Use of steady-state laurdan fluorescence to detect changes in liquid ordered phases in human erythrocyte membranes. J Membr Biol (2006) 0.90
Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLoS One (2015) 0.90
Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. Bone (2011) 0.89
Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. Thromb Res (2011) 0.88
Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity. J Invest Dermatol (2005) 0.86
Extracellular vesicles — new tool for joint repair and regeneration. Nat Rev Rheumatol (2016) 0.86
Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS. J Pharm Biomed Anal (2011) 0.85
Cytosolic phospholipase A2-p11 interaction controls arachidonic acid release as a function of epithelial cell confluence. Biochem J (2004) 0.84
Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations. Int J Mol Sci (2013) 0.84
Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions. J Hematol Oncol (2015) 0.84
Lipid phosphate phosphatases and their roles in mammalian physiology and pathology. J Lipid Res (2015) 0.83
Fibrinolysis in a lipid environment: modulation through release of free fatty acids. J Thromb Haemost (2007) 0.83
Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Atherosclerosis (2012) 0.83
Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion. Biochem J (1996) 0.82
Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects. Blood Transfus (2016) 0.82
Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2. Biochem J (1998) 0.82
Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes. J Clin Invest (1997) 0.80
Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response. J Immunol (2014) 0.79
Human group II 14 kDa phospholipase A2 activates human platelets. Biochem J (1997) 0.79
An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes? J Chem Biol (2010) 0.78
Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies. Front Physiol (2016) 0.78
Promising pharmacological directions in the world of lysophosphatidic Acid signaling. Biomol Ther (Seoul) (2015) 0.78
Visualization of elementary mechanosensitive Ca2+-influx events, Ca2+ spots, in bovine lens epithelial cells. J Physiol (2001) 0.77
Alteration of Lysophosphatidylcholine-Related Metabolic Parameters in the Plasma of Mice with Experimental Sepsis. Inflammation (2016) 0.76
Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease. Br J Haematol (2014) 0.76
Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain. J Neurochem (2015) 0.76
Synovial fluid pretreatment with hyaluronidase facilitates isolation of CD44+ extracellular vesicles. J Extracell Vesicles (2016) 0.75
Endocannabinoids as Guardians of Metastasis. Int J Mol Sci (2016) 0.75
Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tract. Mediators Inflamm (2014) 0.75
C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms. Neth Heart J (2002) 0.75
Binding and internalization of extracellular type-I phospholipase A2 in uterine stromal cells. Biochem J (1996) 0.75
CD14 Is a Key Mediator of Both Lysophosphatidic Acid and Lipopolysaccharide Induction of Foam Cell Formation. J Biol Chem (2017) 0.75
A role for phosphoinositide 3-kinase in bacterial invasion. Science (1996) 2.46
Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. Nature (1993) 2.00
The isolation of porcine ribonuclease, a glycoprotein, from pancreatic juice. J Biol Chem (1968) 1.83
Structure of the pancreatic lipase-procolipase complex. Nature (1992) 1.76
High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis (1989) 1.69
Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol (1997) 1.64
Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol (1998) 1.59
Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol (1995) 1.57
Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase. Biochimie (1978) 1.56
A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. J Biol Chem (2000) 1.56
A genetic defect in phosphatidylcholine biosynthesis triggers apoptosis in Chinese hamster ovary cells. J Biol Chem (1996) 1.52
A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J Lipid Res (2000) 1.42
Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation. Anesth Analg (1995) 1.41
Frozen shoulder: a new delayed complication of protease inhibitor therapy? . Rev Rhum Engl Ed (1998) 1.39
[Treatment of Horton disease. Value of synthetic antimalarials. Apropos of a retrospective study of 36 patients]. Rev Rhum Ed Fr (1994) 1.38
Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. J Biol Chem (1991) 1.37
The intergroup rhabdomyosarcoma study: a preliminary report. Cancer (1977) 1.29
Neonatal rhabdomyosarcoma: the IRS experience. J Pediatr Surg (1994) 1.27
Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis. Biochem J (1995) 1.26
Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Lett (1997) 1.25
Positional specific hydrolysis of phospholipids by pancreatic lipase. Biochim Biophys Acta (1965) 1.25
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood (1990) 1.20
Minireview on pancreatic lipase and colipase. Biochimie (1988) 1.17
Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia (2005) 1.15
Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis (2001) 1.15
Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets. Nature (1981) 1.15
Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med (1997) 1.15
Lipid products of phosphoinositide 3-kinase interact with Rac1 GTPase and stimulate GDP dissociation. J Biol Chem (1998) 1.15
Studies on the effect of bile salt and colipase on enzymatic lipolysis. Improved method for the determination of pancreatic lipase and colipase. Biochimie (1975) 1.13
Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol (1999) 1.12
Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig. Biochim Biophys Acta (1984) 1.11
Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets. J Biol Chem (1998) 1.10
Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediat (2001) 1.09
Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem (1994) 1.09
Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost (2011) 1.08
Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture. Thromb Res (1999) 1.07
Sarcomas of the vagina and uterus: the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg (1985) 1.07
Relationship between phosphoinositide kinase activities and protein tyrosine phosphorylation in plasma membranes from A431 cells. Biochem J (1990) 1.06
Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3',4'-bisphosphate. J Biol Chem (1991) 1.06
Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators? Biochem Biophys Res Commun (1982) 1.05
An epidermal growth factor receptor/Gab1 signaling pathway is required for activation of phosphoinositide 3-kinase by lysophosphatidic acid. J Biol Chem (1999) 1.05
Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: evidence for a critical role of cholesterol-enriched domains in human platelet activation. Biochemistry (2001) 1.05
Characterization and properties of a phosphatidylinositol phosphodiesterase (phospholipase C) from platelet cytosol. FEBS Lett (1979) 1.04
Action of organophosphates on pancreatic lipase. Biochim Biophys Acta (1969) 1.04
Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1. Biochem Biophys Res Commun (1998) 1.03
Chemotherapy for acute lymphocytic leukemia: cognitive and academic sequelae. J Pediatr (1992) 1.00
[Anti-stratum corneum antibody in the rat esophagus, anti-epidermal keratin and anti-epidermis autoantibodies in rheumatoid polyarthritis and other rheumatic diseases. Diagnostic value and basic aspects]. Rev Rhum Mal Osteoartic (1986) 1.00
The novel inositol lipid phosphatidylinositol 3,4-bisphosphate is produced by human blood platelets upon thrombin stimulation. Biochem J (1990) 1.00
Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets. J Biol Chem (1997) 1.00
An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients. AIDS (2001) 0.99
Biochemical characterization of plasma membranes and intracellular membranes isolated from human platelets using Percoll gradients. Biochim Biophys Acta (1986) 0.99
Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison. Gastroenterology (1996) 0.98
Cytidylyltransferase translocation onto endoplasmic reticulum and increased de novo synthesis without phosphatidylcholine accumulation in Krebs-II ascite cells. Biochim Biophys Acta (1991) 0.97
The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol (2000) 0.97
Isolation and characterization of plasma membranes from krebs II ascite cells using Percoll gradient. Biochim Biophys Acta (1982) 0.97
Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets. FEBS Lett (1983) 0.97
Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study. Cancer (1986) 0.97
Differential activation by fMet-Leu-Phe and phorbol ester of a plasma membrane phosphatidylcholine-specific phospholipase D in human neutrophil. FEBS Lett (1989) 0.96
Phosphatidylcholine cycle and regulation of phosphatidylcholine biosynthesis by enzyme translocation. Biochim Biophys Acta (1994) 0.96
Crystallographic study of the structure of colipase and of the interaction with pancreatic lipase. Protein Sci (1995) 0.96
Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. J Obstet Gynaecol (2008) 0.95
Purification from porcine pancreas of two molecular species with lipase activity. Biochim Biophys Acta (1969) 0.95
Distinction between esterases and lipases: comparative biochemical properties of sequence-related carboxylesterases. Protein Pept Lett (2009) 0.93
Kinetic assay of human gastric lipase on short- and long-chain triacylglycerol emulsions. Gastroenterology (1986) 0.93
Natural IgG to epidermal cytokeratins vs IgG to the stratum corneum of the rat oesophagus epithelium, so-called 'antikeratin antibodies', in rheumatoid arthritis and other rheumatic diseases. J Autoimmun (1991) 0.93
Immunoblotting detection of so-called 'antikeratin antibodies': a new assay for the diagnosis of rheumatoid arthritis. Ann Rheum Dis (1994) 0.92
Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry (1999) 0.92
Identification and quantification of diacylglycerols in HDL and accessibility to lipase. J Lipid Res (1996) 0.92
A critical reevaluation of the phenomenon of interfacial activation. Methods Enzymol (1997) 0.92
Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: a study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res (1994) 0.92
Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells. Biochem J (1993) 0.91
Partial cystectomy in the management of rhabdomyosarcoma of the bladder: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg (1990) 0.91
Human neutrophil phospholipase D activation by N-formylmethionyl-leucylphenylalanine reveals a two-step process for the control of phosphatidylcholine breakdown and oxidative burst. Biochem J (1992) 0.91
Cognitive status of children treated with central nervous system prophylactic chemotherapy for acute lymphocytic leukemia. Arch Clin Neuropsychol (1992) 0.91
Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets. Biochem J (1993) 0.90
Association of phosphatidylinositol kinase and phosphatidylinositol 4-phosphate kinase activities with the cytoskeleton in human platelets. FEBS Lett (1989) 0.89
Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thromb Res (1987) 0.89
Studies on the detergent inhibition of pancreatic lipase activity. J Lipid Res (1983) 0.89
Vascular smooth muscle cell spreading onto fibrinogen is regulated by calpains and phospholipase C. Biochem Biophys Res Commun (2001) 0.89
Lipid products of phosphoinositide 3-kinase and phosphatidylinositol 4',5'-bisphosphate are both required for ADP-dependent platelet spreading. J Biol Chem (1998) 0.89
Purification of two lipases with high phospholipase A1 activity from guinea-pig pancreas. Biochim Biophys Acta (1981) 0.88
Activation of phospholipase C in thrombin-stimulated platelets does not depend on cytoplasmic free calcium concentration. FEBS Lett (1984) 0.88
Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation. Cancer Res (1998) 0.88
Crystallization of pancreatic procolipase and of its complex with pancreatic lipase. J Mol Biol (1993) 0.88